AstraZeneca Pharma India Limited

Web: astrazenecaindia.com NSE: ASTRAZEN BSE: 506820 SECTOR: Healthcare - Pharmaceuticals & Biotechnology

7895 136(-2%)

Near 52W Low of 7552

Volume

3k as on 22, Jul

Open

8,950

High

9,060

Low

8,936

8,031

VWAP

8,006

52 Week High

9,850

52 Week Low

7,552

Viand Research Rating

Quality Score

40/100

Growth Score

90/100

Valuation Score

50/100

Momentum Score

0/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

19,738

No. of Shares

2.5

P/E

198.67

P/B

23.96

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

12.06

ROCE

Profit Growth

Listing Date

04-May-01

Promoter Holding

75%

FII Holding

2.78%

DII Holding

5.79%

Price Chart

Price Performance

1 Week3%

1 Month7%

3 Months5%

6 Months4%

1 Year10%

YTD9%

Moving Average

5 Day SMA8,051

10 Day SMA8,120

20 Day SMA8,182

30 Day SMA8,263

50 Day SMA8,387

61 Day SMA8,389

80 Day SMA8,347

200 Day SMA8,677

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	8,262	8,123	8,186	8,238
Resistance 2	8,186	8,111	8,138	8,174
Resistance 1	8,137	8,100	8,109	8,114
Pivot Point	8,061	8,088	8,061	8,049
Support 1	8,012	8,077	8,013	7,989
Support 2	7,936	8,066	7,984	7,925
Support 3	7,888	8,054	7,936	7,865

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,68,075	1951	0%	4%	19%	16%	37	57.7	0.07	11509
2	DIVISLAB	1,93,367	7284	2%	9%	22%	11%	69	57.7	0	2568
3	TORNTPHARM	1,71,221	5059	0%	13%	25%	42%	72	57.7	1.79	2138
4	APOLLOHOSP	1,27,077	8838	0%	6%	31%	21%	58	57.7	0.9	2003
5	CIPLA	1,13,284	1402	2%	0%	3%	4%	22	57.7	0.02	3862
6	ZYDUSLIFE	1,11,092	1114	3%	4%	27%	17%	20	57.7	0.46	5124
7	LUPIN	1,09,480	2394	3%	3%	11%	25%	23	57.7	0.29	5355
8	MAXHEALTH	1,05,425	1083	2%	1%	8%	14%	0	57.7	0.32	1442
9	MANKIND	1,05,070	2544	0%	0%	18%	3%	49	57.7	0.39	1938
10	DRREDDY	97,179	1165	4%	8%	3%	5%	20	57.7	0.2	4158
Load More

Shareholding Pattern (%)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 75.00%	(0.01) 75.00%	(0.01) 75.00%	(0.01) 75.00%	(0.01) 75.00%	(0.01) 75.00%	(0.01) 75.00%	(0.01) 75.00%	(0.01) 75.00%	(0.01) 75.00%	(0.01) 75.00%	(0.01) 75.00%	(0.01) 75.00%	(0.01) 75.00%	(0.01) 75.00%	(0.01) 75.00%	(0.01) 75.00%	(0.01) 75.00%	(0.01) 75.00%
FIIs	(0.11) 2.78%	(0.01) 2.71%	(-0.31) 2.74%	(0.11) 3.03%	(0.01) 2.89%	(0.01) 2.92%	(0.11) 2.90%	(0.11) 2.79%	(0.11) 2.73%	(0.01) 2.66%	(0.01) 2.69%	(0.01) 2.68%	(0.11) 2.70%	(0.11) 2.61%	(0.01) 2.49%	(0.11) 2.48%	(0.01) 2.38%	(0.01) 2.38%	(0.01) 2.40%
DIIs	(0.21) 5.79%	(0.31) 5.55%	(0.71) 5.26%	(-0.11) 4.55%	(-0.61) 4.65%	(0.11) 5.21%	(0.11) 5.08%	(1.21) 4.99%	(1.01) 3.77%	(0.31) 2.76%	(0.51) 2.42%	(0.51) 1.91%	(0.01) 1.41%	(0.11) 1.42%	(0.01) 1.32%	(0.11) 1.30%	(0.11) 1.19%	(0.11) 1.14%	(0.01) 1.05%
Public	16.42%	16.73%	17.00%	17.41%	17.45%	16.85%	17.02%	17.21%	18.50%	19.57%	19.89%	20.40%	20.88%	20.97%	21.19%	21.22%	21.43%	21.48%	21.55%
No. of Shareholders	29,007	31,551	32,914	34,378	32,466	27,322	27,615	27,169	29,418	29,032	32,380	38,946	42,146	45,619	49,085	53,980	57,760	62,183	66,444

Quarterly Results

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Sales	579	612	559	526	480	440	408	388	383	306	311	295	285	250	236	232	232	201	198
Sales Growth % (YoY)	20.4%	38.9%	37%	35.8%	25.4%	44%	31.2%	31.2%	34.6%	22.4%	31.7%	27.2%	22.7%	24.6%	19.4%	32.5%	10.3%	0.1%	-5.6%
Sales Growth % (QoQ)	-5.4%	9.5%	6.3%	9.6%	9.1%	7.8%	5.2%	1.3%	25.2%	-1.6%	5.4%	3.5%	14%	5.9%	1.7%	-	15.4%	1.5%	-
Expenses	518	567	484	445	394	363	355	349	334	291	258	228	225	213	195	204	194	186	180
Operating Profit	61	45	75	81	86	77	53	38	49	15	53	67	60	37	41	28	38	15	18
OPM %	11	7	13	15	18	17	13	10	13	5	17	23	21	15	17	12	16	7	9
Other Income	5	7	1	11	10	-26	8	-49	9	10	25	8	-32	7	7	4	4	5	3
Interest	2	1	1	1	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0
Depreciation	6	4	3	17	18	9	9	4	4	4	4	4	4	4	3	5	4	4	4
Profit before tax	58	47	73	75	78	42	51	-15	54	20	73	71	23	39	44	27	37	16	16
Tax %	23	30	26	25	26	27	25	-22	27	23	29	25	26	26	26	26	24	30	26
Net Profit	45	33	54	56	58	31	38	-12	39	16	52	54	17	29	33	20	28	11	12
Net Profit Growth % (QoQ)	36.4%	-38.9%	-3.6%	-3.4%	87.1%	-18.4%	416.7%	-130.8%	143.8%	-69.2%	-3.7%	217.6%	-41.4%	-12.1%	65%	-28.6%	154.5%	-8.3%	-
Net Profit Growth % (YoY)	-22.4%	6.5%	42.1%	566.7%	48.7%	93.8%	-26.9%	-122.2%	129.4%	-44.8%	57.6%	170%	-39.3%	163.6%	175%	-	-	-	-
TTM Net Profit	188	201	199	183	115	96	81	95	161	139	152	133	99	110	92	71	51	23	0
EPS in Rs	17.95	13.04	21.69	22.33	23.3	12.34	15.37	-4.72	15.79	6.32	20.95	21.54	6.91	11.72	13.02	8.06	11.19	4.57	4.78

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Sales	2276	1716	1296	1003	806	814	832	728	571	544	564	517	474	390
Sales Growth %	32.6%	32.5%	29.2%	24.5%	-1%	-2.2%	14.2%	27.6%	5%	-3.6%	9%	9.1%	21.4%	-26.5%
Expenses	2014	1462	1111	838	719	678	711	657	525	506	547	528	487	459
Operating Profit	262	254	184	165	86	135	121	71	46	37	16	-11	-13	-68
OPM %	12	15	14	16	11	17	15	10	8	7	3	-2	-3	-18
Other Income	23	-56	51	-14	15	13	13	16	12	14	7	6	23	10
Interest	4	1	1	1	1	1	1	0	0	0	0	0	0	0
Depreciation	29	40	15	16	17	20	19	15	15	16	17	15	10	12
Profit before tax	252	156	220	134	83	127	114	73	44	36	6	-21	0	-70
Tax %	26	26	26	26	26	27	37	25	41	44	9	0	0	27
Net Profit	188	116	162	99	62	93	72	54	26	20	5	-21	-1	-90
Net Profit Growth %	62.1%	-28.4%	63.6%	59.7%	-33.3%	29.2%	33.3%	107.7%	30%	300%	123.8%	-2000%	98.9%	-
EPS in Rs	75.01	46.3	64.6	39.72	24.64	37.32	28.88	21.78	10.36	8.02	2.1	-8.34	-0.2	-35.81
Dividend Payout %	48	69	37	40	41	5	3	0	0	0	0	0	0	0

Cash Flows

	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Cash from Operating Activity	65	28	58	101	105	87	55	9	38	57	-46	-1	-6
Cash from Investing Activity	31	22	18	5	173	-171	4	-9	0	-4	-19	-15	-16
Cash from Financing Activity	-66	-44	-24	-9	-9	-6	0	0	0	-1	0	86	-10
Net Cash Flow	31	5	52	96	269	-90	59	-1	38	53	-64	71	-32

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Equity Capital	5	5	5	5	5	5	5	5	5	5	5	5	5	5	5	5
Reserves	868	794	765	674	707	584	506	451	359	296	242	218	151	146	167	95
Borrowings	111	35	36	17	5	7	9	12	12	0	0	0	0	0	0	0
Other Liabilities	1006	781	712	545	362	389	337	306	330	261	214	193	247	261	244	206
Total Liabilities	1989	1615	1518	1241	1078	985	857	775	706	562	461	415	403	412	416	306
Fixed Assets	117	40	64	69	67	69	74	81	72	75	75	87	97	101	94	25
CWIP	0	0	0	0	0	1	2	4	24	7	4	5	6	12	9	74
Investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Assets	1872	1575	1454	1172	1011	915	780	690	611	480	382	324	299	298	312	208
Total Assets	1989	1615	1518	1241	1078	985	857	775	706	562	461	415	403	412	416	306

Delivery

#	Date	7900 16% 9150	Value (Cr)	Q/T 3	Del 44	Del 16
1	22-Jul	8031	3	3	53	1
2	21-Jul	8088	4	5	62	3
3	20-Jul	8054	5	3	50	2
4	17-Jul	8024	7	5	50	4
5	16-Jul	8086	5	3	40	2
6	15-Jul	8228	7	3	60	4
7	14-Jul	8198	5	2	49	2
8	13-Jul	8291	10	3	51	5
9	10-Jul	8118	4	4	55	2
10	9-Jul	8114	2	3	62	1
11	8-Jul	8141	4	3	54	2
12	7-Jul	8204	3	3	53	2
13	6-Jul	8236	1	2	46	1
14	3-Jul	8310	4	3	55	2
15	2-Jul	8242	3	2	69	2
16	1-Jul	8176	5	3	56	3
17	30-Jun	8226	5	4	56	3
18	29-Jun	8058	42	4	65	27
19	25-Jun	8391	1	2	54	0
20	24-Jun	8442	2	2	51	1
21	23-Jun	8513	4	2	44	2
22	22-Jun	8570	6	3	62	4
23	19-Jun	8434	6	3	55	3
24	18-Jun	8529	2	2	45	1
25	17-Jun	8512	1	2	31	0
26	16-Jun	8503	3	3	44	1
27	15-Jun	8424	6	2	42	2
28	12-Jun	8250	3	2	43	1
29	11-Jun	8228	8	2	19	2
30	10-Jun	8288	7	3	44	3
31	9-Jun	8453	4	2	40	1
32	8-Jun	8344	4	3	56	2
33	5-Jun	8600	5	4	55	3
34	4-Jun	8514	7	3	30	2
35	3-Jun	8557	3	3	50	1
36	2-Jun	8710	4	3	52	2
37	1-Jun	8729	8	3	36	3
38	29-May	8632	26	3	58	15
39	27-May	8648	69	5	47	32
40	26-May	8962	24	3	37	9
41	25-May	8800	8	3	55	4
42	22-May	8588	1	2	46	1
43	21-May	8590	4	3	42	2
44	20-May	8610	6	3	39	2
45	19-May	8696	5	3	58	3
46	18-May	8514	4	3	41	2
47	15-May	8468	3	3	58	2
48	14-May	8352	1	2	58	1

Daily Market Cap

Date	Total Market Cap	Change	Chg %
23-Jul	19,738c	266c	1.33
22-Jul	20,004c	196c	0.97
21-Jul	20,200c	149c	0.74
17-Jul	20,051c	161c	0.80
16-Jul	20,213c	474c	2.29
15-Jul	20,686c	129c	0.63
14-Jul	20,558c	368c	1.76
13-Jul	20,925c	675c	3.33
10-Jul	20,250c	45c	0.22
09-Jul	20,295c	20c	0.10
08-Jul	20,315c	159c	0.78
07-Jul	20,474c	144c	0.70
06-Jul	20,618c	88c	0.43
02-Jul	20,530c	183c	0.88
01-Jul	20,713c	148c	0.72
30-Jun	20,565c	180c	0.87
29-Jun	20,745c	355c	1.68
26-Jun	21,100c	86c	0.41
25-Jun	21,186c	110c	0.52
24-Jun	21,076c	126c	0.60
23-Jun	21,203c	238c	1.11
22-Jun	21,440c	303c	1.43
19-Jun	21,138c	185c	0.87
17-Jun	21,323c	49c	0.23
16-Jun	21,274c	249c	1.18
15-Jun	21,025c	444c	2.16
12-Jun	20,581c	311c	1.49
10-Jun	20,893c	0	0

Stock Checklist

Price is below from 52 week high low average: 70%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: NO

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: YES

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 85 fund scheme(s) across 17 fund house(s) as of Jul26 · Total value ₹2,468 Cr · 13 increasing / 12 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
Nippon India Mutual Fund	6	0.73%	-	1187.5
ICICI Prudential Mutual Fund	26	0.51%	+0.09%	571.8
Bandhan Mutual Fund	12	12.43%	-	499
Baroda BNP Paribas Mutual Fund	6	2.56%	-	134
UTI Mutual Fund	4	0.64%	-	35.4
ICICI Prudential Asset Management Company Limited	1	0.30%	+0.30%	28
Bajaj Finserv Mutual Fund	2	0.76%	-0.07%	5.4
Edelweiss Mutual Fund	4	0.35%	-	4
Axis Mutual Fund	4	0.43%	-	1.1
Groww Mutual Fund	2	0.43%	-	0.6
Navi Mutual Fund	2	0.81%	-	0.5
Angel One Mutual Fund	4	0.33%	-	0.2
Motilal Oswal Mutual Fund	2	0.03%	-	0
HDFC Mutual Fund	2	0.00%	-0.03%	0
Mirae Asset Mutual Fund	2	0.00%	-	0
DSP Mutual Fund	4	0.00%	-	0
WhiteOak Capital Mutual Fund	2	0.00%	-0.95%	0

AstraZeneca Pharma India Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements